The Invesco Dorsey Wright Healthcare Momentum ETF (PTH) seeks to track healthcare stocks exhibiting strong price momentum using the Dorsey Wright Healthcare Technical Leaders Index. This momentum-based strategy identifies healthcare companies with the strongest relative price performance trends over multiple time periods, focusing on stocks showing sustained upward price movement.

How It Works

PTH uses a quantitative momentum scoring system that ranks healthcare stocks based on relative strength across multiple timeframes, from short-term to intermediate-term price trends. The Dorsey Wright methodology employs point-and-figure charting techniques to identify stocks with the most consistent upward momentum patterns. Holdings are equal-weighted and rebalanced quarterly, with momentum scores recalculated regularly to capture changing price trends. The fund typically holds 40-60 healthcare stocks across pharmaceuticals, biotechnology, medical devices, and healthcare services sectors.

Key Features

  • Pure-play momentum strategy within healthcare sector, avoiding traditional fundamental analysis in favor of technical price trends
  • Equal-weighting approach prevents large-cap pharmaceutical dominance seen in market-cap weighted healthcare ETFs
  • Quarterly rebalancing captures evolving momentum patterns while avoiding excessive turnover costs

Risks

  • This ETF can lose value rapidly when healthcare momentum reverses, as momentum stocks often decline faster than fundamentally-driven investments during sector rotations
  • High turnover from quarterly rebalancing creates tax inefficiency and transaction costs that can drag performance during volatile periods
  • Healthcare sector concentration exposes investors to regulatory risks, drug approval failures, and sector-wide selloffs that could cause 20-30% declines

Who Should Own This

Best suited as a tactical satellite holding (5-15% of portfolio) for aggressive investors with 6-18 month time horizons seeking to capitalize on healthcare sector momentum. High risk tolerance required due to momentum strategy volatility and sector concentration. Appropriate for investors who can actively monitor and exit positions when momentum trends reverse.